Search research articles
Contact Us
Filters
Showing results (71-80 of 352) with videos related to
Page
of 36
Sort By:
Advanced Materials (Deerfield Beach, Fla.)
|
September 9, 2010
Switchable transparency and wetting of elastomeric smart windows
Seung Goo Lee, Dong Yun Lee, Ho Sun Lim, et al.
Journal of Veterinary Science
|
March 29, 2014
Effects of resveratrol on the insulin signaling pathway of obese mice
Hyun Ju Hong, Wonyoung Kang, Dong Geon Kim, et al.
Diabetes & Metabolism Journal
|
August 14, 2025
Dynamic Lipidomic Remodeling and Clinical Correlations after Sleeve Gastrectomy in Obese Subjects
Gakyung Lee, Yeong Chan Lee, Minkuk Park, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
May 23, 2019
Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects
Dongseong Shin, Young Sil Eom, Suk Chon, et al.
Annals of Hematology
|
October 22, 2009
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma
Jeong Eun Kim, Changhoon Yoo, Dae Ho Lee, et al.
The Korean Journal of Internal Medicine
|
July 1, 2011
False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination
Jeong-Eun Kim, Eun Kyoung Kim, Dae Ho Lee, et al.
Anticancer Research
|
October 4, 2011
Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study
Dae Ro Choi, Dae Ho Lee, Chang-Min Choi, et al.
Cancer Research and Treatment
|
February 13, 2015
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
Dae Ho Lee, Jung Shin Lee, Jie Wang, et al.
The Korean Journal of Hematology
|
July 13, 2011
Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
Geundoo Jang, Dok Hyun Yoon, Shin Kim, et al.
Gut and Liver
|
May 21, 2010
Infarction and Perforation of the Small Intestine due to Tumor Emboli from Disseminated Rectal Cancer
Jae-Cheol Jo, Dae Ho Lee, Ho June Song, et al.
Page
of 36
Search research articles
Search
Showing results (71-80 of 352) with videos related to
Sort By:
Page
of 36
Advanced Materials (Deerfield Beach, Fla.)
|
September 9, 2010
Switchable transparency and wetting of elastomeric smart windows
Seung Goo Lee, Dong Yun Lee, Ho Sun Lim, et al.
Journal of Veterinary Science
|
March 29, 2014
Effects of resveratrol on the insulin signaling pathway of obese mice
Hyun Ju Hong, Wonyoung Kang, Dong Geon Kim, et al.
Diabetes & Metabolism Journal
|
August 14, 2025
Dynamic Lipidomic Remodeling and Clinical Correlations after Sleeve Gastrectomy in Obese Subjects
Gakyung Lee, Yeong Chan Lee, Minkuk Park, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
May 23, 2019
Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects
Dongseong Shin, Young Sil Eom, Suk Chon, et al.
Annals of Hematology
|
October 22, 2009
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma
Jeong Eun Kim, Changhoon Yoo, Dae Ho Lee, et al.
The Korean Journal of Internal Medicine
|
July 1, 2011
False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination
Jeong-Eun Kim, Eun Kyoung Kim, Dae Ho Lee, et al.
Anticancer Research
|
October 4, 2011
Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study
Dae Ro Choi, Dae Ho Lee, Chang-Min Choi, et al.
Cancer Research and Treatment
|
February 13, 2015
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
Dae Ho Lee, Jung Shin Lee, Jie Wang, et al.
The Korean Journal of Hematology
|
July 13, 2011
Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
Geundoo Jang, Dok Hyun Yoon, Shin Kim, et al.
Gut and Liver
|
May 21, 2010
Infarction and Perforation of the Small Intestine due to Tumor Emboli from Disseminated Rectal Cancer
Jae-Cheol Jo, Dae Ho Lee, Ho June Song, et al.
Page
of 36